21 May 2013
Keywords: pfizer/pharmacia, celebrex, tops, leading, nsaids, gi, safety
Article | 15 September 2000
Pfizer and Pharmacia subsidiary Searle's selective COX-2 inhibitorCelebrex (celecoxib) has been shown to be associated with a lower rate
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 September 2000
12 September 2000
15 September 2000
© 2013 thepharmaletter.com